Home » Authors » Karen Young

Articles by Karen Young

Vasogen CHF Immune Therapy Succeeds In Phase II CHF Study

March 1, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Amgen Ends Deal With Bioject On Needle-Free Delivery Systems

Feb. 28, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Paradigm Enters MetaVantage Alliance With VDDI, Fires CEO

Feb. 27, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Confirmant Unveils Protein Atlas Database For Drug Discovery

Feb. 26, 2002

Angiotech Comes Up Short In Phase II Multiple Sclerosis Study

Feb. 26, 2002

Restoragen Cuts Half Its Staff, Plans To Rework Business Plan

Feb. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...